We are Scotland's dementia charity

October is now drawing to a close and this weekend, on 27 October at 2am, the clocks will move back one hour.  

Today, the UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), approved a second Alzheimer’s drug, donanemab, for use in the UK. However, an interim provisional decision by the National Institute for Health and Care Excellence (NICE) has deemed donanemab not cost-effective for the NHS. As a result, for now at least, the drug will only be available privately.

On Friday 20 September, we welcomed almost 400 delegates to the Edinburgh International Conference Centre (EICC) for our Annual Conference. The theme for the day was ‘Your choice, Your voice, Your future’.